Trial Profile
A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2021
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors Shire
- 01 Jun 2015 New trial record